Profusa, Inc. Common Stock (PFSA) is a publicly traded Healthcare sector company. As of May 21, 2026, PFSA trades at $0.41 with a market cap of $1.92M and a P/E ratio of -0.00. PFSA moved +1.11% today. Year to date, PFSA is -93.58%; over the trailing twelve months it is flat. Its 52-week range spans $0.39 to $180.00. Rallies surfaces PFSA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Profusa Moves to Nasdaq Capital Market Tier to Meet Compliance Milestones: Profusa will be listed on the Nasdaq Capital Market effective May 15, 2026, marking the first milestone in its Nasdaq Hearings Panel–mandated compliance plan. The transfer aims to satisfy bid-price and stockholders’ equity requirements to maintain its Nasdaq listing.
| Metric | Value |
|---|---|
| Price | $0.41 |
| Market Cap | $1.92M |
| P/E Ratio | -0.00 |
| EPS | $-107.01 |
| Dividend Yield | 0.00% |
| 52-Week High | $180.00 |
| 52-Week Low | $0.39 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-35.82M |
| Gross Margin | 0.00% |
PFSA analyst coverage data. Average price target: $0.00.